Incidentally, glucose-regulated protein 75 (GRP75) inhibitor is effective to correct the pro-fission activation induced by the ApoE4 (Δ272–299) (Liang et al., 2021b), indicating a promising insight for AD-targeted therapy. The gene discussed is APOE; the disease is Alzheimer disease.